IBB
iShares Biotechnology ETF
1W: +1.2%
1M: -6.0%
3M: -4.1%
YTD: -1.9%
1Y: +22.7%
3Y: +32.8%
5Y: +9.6%
$165.26
-0.49 (-0.30%)
After Hours: $165.19 (-0.06, -0.04%)
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Weather
ETF-Level Metrics
AUM$7.9B
Holdings246
Top 10 Wt50.1%
Beta0.98
% Profitable17%
Coverage100%
Portfolio Valuation
P/E24.7
P/B6.6
P/S6.2
EV/EBITDA16.0
P/FCF24.0
PEG2.13
Profitability & Returns
Gross Margin83.7%
Net Margin23.0%
ROE26.0%
ROA10.0%
ROIC17.1%
Div Yield0.50%
Leverage & Liquidity
Debt/Equity0.96
Debt/Assets0.38
Net Debt/EBITDA1.1x
Interest Cov8.1x
Current Ratio1.87
Quick Ratio1.55
Growth (YoY)
Revenue+31.2%
Net Income+65.3%
EPS+69.5%
FCF+41.2%
EBITDA+66.5%
Rev CAGR 3Y+31.6%
Quality Scores
Piotroski F5.6
Altman Z10.45
IS Quality66.8
IS Overall60.4
IS Value43.6
Median P/E-5.2
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 246 | 99.9% | -13.0 |
| Other | 11 | 0.1% | — |
Smart Money Overlap
4 holdings with signals
Showing 50 of 257 holdings
· Page 1 of 6
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | GILEAD SCIENCES INC | GILD | 9.64% | $768.7M | 5,440,729 | 20.0 | $171.6B | Healthcare |
| 2 | VERTEX PHARMACEUTICALS INC | VRTX | 8.95% | $713.1M | 1,578,979 | 29.2 | $115.6B | Healthcare |
| 3 | AMGEN INC | AMGN | 8.74% | $696.6M | 1,981,880 | 24.7 | $190.8B | Healthcare |
| 4 | REGENERON PHARMACEUTICALS INC | REGN | 6.91% | $550.6M | 739,990 | 17.3 | $77.9B | Healthcare |
| 5 | ALNYLAM PHARMACEUTICALS INC | ALNY | 3.75% | $298.7M | 948,943 | 139.8 | $43.6B | Healthcare |
| 6 | INSMED INC | INSM | 2.75% | $219.5M | 1,537,964 | -24.8 | $32.0B | Healthcare |
| 7 | ARGENX SE ADR | ARGX | 2.54% | $202.7M | 295,987 | 37.7 | $43.1B | Healthcare |
| 8 | BIOGEN INC | BIIB | 2.45% | $195.2M | 1,070,971 | 21.7 | $27.8B | Healthcare |
| 9 | NATERA INC | NTRA | 2.38% | $190.0M | 960,478 | -129.0 | $28.0B | Healthcare |
| 10 | UNITED THERAPEUTICS CORP | UTHR | 2.02% | $161.1M | 303,753 | 17.8 | $23.7B | Healthcare |
| 11 | BEONE MEDICINES AG | ONC | 1.87% | $149.3M | 528,778 | 156.7 | $30.3B | Healthcare |
| 12 | ILLUMINA INC | ILMN | 1.68% | $133.5M | 1,086,089 | 22.6 | $19.3B | Healthcare |
| 13 | MODERNA INC | MRNA | 1.67% | $132.8M | 2,534,609 | -7.4 | $21.1B | Healthcare |
| 14 | INCYTE CORP | INCY | 1.64% | $131.0M | 1,420,076 | 14.2 | $18.4B | Healthcare |
| 15 | REVOLUTION MEDICINES INC | RVMD | 1.49% | $118.6M | 1,208,856 | -15.7 | $18.7B | Healthcare |
| 16 | GENMAB SPONSORED ADR | GMAB | 1.17% | $93.0M | 3,595,754 | 25.7 | $16.1B | Healthcare |
| 17 | NEUROCRINE BIOSCIENCES INC | NBIX | 1.16% | $92.8M | 709,918 | 27.6 | $13.2B | Healthcare |
| 18 | ROIVANT SCIENCES LTD | ROIV | 1.10% | $88.0M | 3,164,494 | -23.7 | $19.6B | Healthcare |
| 19 | BRIDGEBIO PHARMA INC | BBIO | 1.06% | $84.4M | 1,203,278 | -19.6 | $13.9B | Healthcare |
| 20 | IONIS PHARMACEUTICALS INC | IONS | 1.04% | $83.3M | 1,161,634 | -31.7 | $12.0B | Healthcare |
| 21 | EXELIXIS INC | EXEL | 0.98% | $78.3M | 1,898,857 | 14.8 | $11.5B | Healthcare |
| 22 | ASCENDIS PHARMA ADR REPRESENTING | ASND | 0.97% | $77.0M | 338,791 | -51.9 | $13.6B | Healthcare |
| 23 | BIOMARIN PHARMACEUTICAL INC | BMRN | 0.96% | $76.7M | 1,384,339 | 30.6 | $10.7B | Healthcare |
| 24 | MEDPACE HOLDINGS INC | MEDP | 0.94% | $75.2M | 165,248 | 29.5 | $13.2B | Healthcare |
| 25 | MADRIGAL PHARMACEUTICALS INC | MDGL | 0.84% | $66.7M | 150,846 | -40.3 | $10.6B | Healthcare |
| 26 | BIO TECHNE CORP | TECH | 0.72% | $57.2M | 1,125,877 | 101.1 | $8.2B | Healthcare |
| 27 | CHARLES RIVER LABORATORIES INTERNA | CRL | 0.70% | $55.9M | 355,726 | -56.6 | $8.2B | Healthcare |
| 28 | CYTOKINETICS INC | CYTK | 0.68% | $54.5M | 876,719 | -9.9 | $7.7B | Healthcare |
| 29 | HALOZYME THERAPEUTICS INC | HALO | 0.68% | $54.1M | 850,231 | 23.5 | $7.5B | Healthcare |
| 30 | PRAXIS PRECISION MEDICINES INC | PRAX | 0.68% | $53.9M | 186,539 | -22.9 | $6.6B | Healthcare |
| 31 | ARROWHEAD PHARMACEUTICALS INC | ARWR | 0.66% | $52.3M | 921,500 | 41.9 | $8.5B | Healthcare |
| 32 | VAXCYTE INC | PCVX | 0.63% | $50.4M | 928,371 | -9.7 | $8.0B | Healthcare |
| 33 | AXSOME THERAPEUTICS INC | AXSM | 0.60% | $47.8M | 302,790 | -45.5 | $8.3B | Healthcare |
| 34 | ABIVAX AMERICAN DEPOSITARY SHARES | ABVX | 0.60% | $47.7M | 384,974 | -30.8 | $7.3B | Healthcare |
| 35 | BIONTECH SE ADR | BNTX | 0.57% | $45.2M | 502,347 | -16.3 | $22.3B | Healthcare |
| 36 | REPLIGEN CORP | RGEN | 0.57% | $45.8M | 389,358 | 132.0 | $6.4B | Healthcare |
| 37 | KRYSTAL BIOTECH INC | KRYS | 0.57% | $45.6M | 181,965 | 35.6 | $7.5B | Healthcare |
| 38 | PROTAGONIST THERAPEUTICS INC | PTGX | 0.53% | $42.0M | 432,386 | -50.5 | $6.7B | Healthcare |
| 39 | RHYTHM PHARMACEUTICALS INC | RYTM | 0.49% | $39.2M | 456,161 | -28.2 | $5.8B | Healthcare |
| 40 | PTC THERAPEUTICS INC | PTCT | 0.47% | $37.8M | 563,587 | 7.9 | $5.5B | Healthcare |
| 41 | ARCELLX INC | ACLX | 0.45% | $36.2M | 316,556 | -28.2 | $6.7B | Healthcare |
| 42 | TEMPUS AI INC CLASS A | TEM | 0.45% | $36.3M | 744,845 | -32.5 | $8.1B | Healthcare |
| 43 | MIRUM PHARMACEUTICALS INC | MIRM | 0.44% | $35.1M | 382,893 | -191.9 | $4.5B | Healthcare |
| 44 | NUVALENT INC CLASS A | NUVL | 0.43% | $34.1M | 349,618 | -17.4 | $7.2B | Healthcare |
| 45 | KYMERA THERAPEUTICS INC | KYMR | 0.43% | $34.4M | 435,136 | -21.8 | $6.4B | Healthcare |
| 46 | AMICUS THERAPEUTICS INC | FOLD | 0.40% | $31.8M | 2,212,558 | -164.4 | $4.5B | Healthcare |
| 47 | ALKERMES | ALKS | 0.40% | $32.1M | 1,181,876 | 20.5 | $4.9B | Healthcare |
| 48 | CRISPR THERAPEUTICS AG | CRSP | 0.40% | $31.9M | 668,483 | -7.4 | $4.5B | Healthcare |
| 49 | TERNS PHARMACEUTICALS INC | TERN | 0.39% | $31.4M | 658,188 | -51.4 | $4.8B | Healthcare |
| 50 | COGENT BIOSCIENCES INC | COGT | 0.39% | $30.9M | 899,803 | -7.5 | $5.9B | Healthcare |